Get the app
USHealthcare

Intuitive Surgical Inc (ISRG)

US · Healthcare · Medical Instruments & Supplies

$383.54+0.33%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$2.89B
Revenue YoY
+18.5%
Net profit
$818.1M
Profit YoY
+24.3%
EPS
$2.80
EPS estimate
$2.02
Net margin
28.3%

EPS came in at 2.80 against a street estimate of 2.02 — a beat of 38.6%.

Key statistics

Market cap
$132.26B
P/E
41.3
Forward P/E
29.9
P/B
7.01
Book value
$51.34
EPS (TTM)
$8.93
52-week high
$603.88
52-week low
$328.57
50-day MA
$378.12
200-day MA
$460.81
Beta
1.47

Analyst view

Analysts rate Intuitive Surgical Inc a buy (22 buy, 10 hold, 1 sell out of 33) with an average price target of $478.01.

Shareholding

Insiders
0.51%
Institutions
89.50%

Largest institutional holders

FundStake
BlackRock Inc8.51%
Vanguard Capital Management, LLC6.53%
State Street Corp4.49%
T. Rowe Price Associates, Inc.3.54%
Amvescap Plc.3.17%
Geode Capital Management, LLC2.40%
Capital World Investors2.19%
Vanguard Portfolio Management, LLC2.05%

Recent filings & reports

DocumentDate
Charter / bylaws change · Q3 2026
INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Document date: July 23, 2026 • Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) • Fil
2026-07-27
Quarterly report · Q2 2026
INTUITIVE SURGICAL, INC. - Q2 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (6 months): $5,663.1 million, up 20.7% vs. $4,693.4
2026-07-21
Results announced · Q3 2026
INTUITIVE SURGICAL Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $2.89 billion, up 19% vs Q2 2025 ($2.44 billion) • Q2 2026 GAAP Net
2026-07-16
Board / officer change · Q2 2026
INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Filing Date: May 28, 2026 • Company: Intuitive Surgical, Inc. (Ticker: ISRG, Nasdaq)
2026-05-28
Board / officer change · Q2 2026
INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY Filing Date: May 4, 2026 | Annual Meeting: April 30, 2026 --- HEADLINE NUMBERS • Stock repurchase progr
2026-05-04
Quarterly report · Q1 2026
INTUITIVE SURGICAL, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total Revenue: $2,770.8 million (Q1 2026) vs. $2,253.4 million (Q1 2025) – 23.0%
2026-04-22
Proxy statement · Q4 2025
INTUITIVE SURGICAL, INC. PROXY STATEMENT SUMMARY CEO TOTAL COMPENSATION & CHANGE David J. Rosa (New CEO as of July 1, 2025): - For 2025 (6-month per
2026-03-13
Annual report FY2025
INTUITIVE SURGICAL, INC. - 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) • Market capitaliza
2026-02-03

Readable in the app.

Deals & corporate news

AnnouncementDate
Completed acquisition of da Vinci and Ion distribution business
Intuitive Surgical completed its acquisition of the da Vinci and Ion distribution business from ab medica, Abex, Excelencia Robótica, and their affiliates on March 1, 2026. The company annou
2026-03-02

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Intuitive Surgical Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.